Physiological processes such as glycan degradation and ubiquitin-mediated proteolysis significantly inhibit the occurrence and development of cancer, and there are common signaling pathways in cancer, MAPK signaling pathway, and the p53 signaling pathway (Figure 6). This evidence concerns the gene TP53 and cancer.